1-4 of 4
Harre Downey
Close
Sort by
Journal Articles

Efficacy and Safety of Continuous Expression of An Improved Variant of FVIIa On Murine Hemostasis with or without Inhibitors to Human Factor IX.

Elise Roy, Armida Faella, Harre Downey, Lacramioara Ivanciu, Ph.D., Shangzhen Zhou, Katherine A. High, MD, Paris Margaritis, D.Phil
Journal: Blood
Blood (2009) 114 (22): 2466.
https://doi.org/10.1182/blood.V114.22.2466.2466
Published: 2009
Journal Articles

Successful and Safe Treatment of Canine Hemophilia by Continuous Expression of Canine FVIIa: a Model for FVIII/FIX Gene-Based Bypassing Agents

Paris Margaritis, Elise Roy, Majed N Aljamali, Harre Downey, Shangzhen Zhou, Elizabeth Merricks, Aaron Dillow, Timothy C Nichols, Katherine A. High, MD
Journal: Blood
Blood (2008) 112 (11): lba-4.
https://doi.org/10.1182/blood.V112.11.lba-4.lba-4
Published: 2008
Journal Articles

Factor Xa Variants as Novel Bypass Agents for the Treatment of Hemophilia in Murine Models

Lacramioara Ivanciu, Ph.D., Raffaella Toso, Ph.D., Alexander Schlachterman, M.D., Harre Downey, B.S., Jian-Hua Liu, B.S., Valder R. Arruda, M.D., Ph.D., Rodney M. Camire, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 239.
https://doi.org/10.1182/blood.V112.11.239.239
Published: 2008
Journal Articles

Nonsense Suppression Approaches in Treating Hemophilia

Yi-Lin Liu, Paris Margaritis, Fayaz Khazi, Harre Downey, Stephan Kadauke, Nicole Hasbrouck, Josephine Sheedy, Ellen Welch, Marla Weetall, Katherine A. High, MD
Journal: Blood
Blood (2008) 112 (11): 512.
https://doi.org/10.1182/blood.V112.11.512.512
Published: 2008